[Federal Register Volume 67, Number 86 (Friday, May 3, 2002)]
[Notices]
[Pages 22436-22437]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-10983]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Correction

ACTION: Notice; Correction.

-----------------------------------------------------------------------

    In the Federal Register of April 17, 2002, Volume 67, Number 74, 
Page 18911 the following should read as follows:

Correction

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

Centers for Disease Control and Prevention: Meeting

    The Centers for Disease Control and Prevention (CDC) announces the 
following committee meeting:

    Name: Advisory Committee on Immunization Practices, Smallpox 
Working Group.
    Times and Dates:

9 a.m.-12 p.m., May 8, 2002 (Closed).
1 p.m.-9 p.m., May 8, 2002.
8:30 a.m.-11:30 a.m., May 9, 2002.

    Place: Atlanta Marriott Century Center, 2000 Century Boulevard, 
NE, Atlanta, Georgia 30345-3377.
    Status: Closed 9 a.m.-12 p.m., May 8, 2002. Remainder of meeting 
open to the public, limited only by the space available.
    Purpose: The working group will convene in closed session from 9 
a.m.-12 a.m., May 8, 2002. During the open session the working group 
will gather information and formulate options to be presented to the 
Advisory Committee on Immunization Practices for its deliberation in 
making recommendations for the use of vaccinia (smallpox) vaccine.

[[Page 22437]]

    Matters To Be Discussed: The panel will gather information 
regarding the use of vaccinia (smallpox) vaccine.
    Contact Person for More Information: Gloria A. Kovach, Program 
Analyst, Epidemiology and Surveillance Division, National 
Immunization Program, CDC,1600 Clifton Road, NE, m/s E61, Atlanta, 
Georgia 30333. Telephone 404/639-8096.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings for both the Centers for Disease 
Control and Prevention and the Agency for Toxic Substances and 
Disease Registry.

    Dated: April 29, 2002.
John Burckhardt,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 02-10983 Filed 5-2-02; 8:45 am]
BILLING CODE 4163-18-P